TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research April 27, 1979